MYELOPROLIFERATIVE DISORDERS
Clinical trials for MYELOPROLIFERATIVE DISORDERS explained in plain language.
Never miss a new study
Get alerted when new MYELOPROLIFERATIVE DISORDERS trials appear
Sign up with your email to follow new studies for MYELOPROLIFERATIVE DISORDERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to tame dangerous immune storms after cancer transplants
Disease control OngoingThis early-stage study is testing whether a drug called itacitinib can make stem cell transplants safer for older patients with blood cancers. The goal is to prevent a severe, potentially life-threatening immune reaction called cytokine release syndrome (CRS) that can occur after…
Matched conditions: MYELOPROLIFERATIVE DISORDERS
Phase: PHASE1 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Scientists hunt root causes of blood cancers in major research effort
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to discover what causes blood and bone marrow cancers like leukemia. Researchers will analyze cancer cells from up to 5,000 participants to find the specific abnormalities that make the cells grow. The goal is to use this knowledge to develop more effective and le…
Matched conditions: MYELOPROLIFERATIVE DISORDERS
Sponsor: OHSU Knight Cancer Institute • Aim: Knowledge-focused
Last updated Apr 01, 2026 21:26 UTC